VGI Health Technology Limited (NSX:VTL) is pleased to announce that Dr Jordan Moon, a member of its Scientific Advisory Board, will be presenting an abstract at the American Society for Nutrition (ASN) Annual Conference, Nutrition 2022.
Nanollose Limited (ASX:NC6) (FRA:N0L) is commercialising scalable technology to create tree-free fibres with minimal environmental impact.
iQX Limited (NSX:IQX) today announced it has received a worldwide license from Harvard's Office of Technology Development to commercialise diagnostic technology developed at the Wyss Institute for Biologically Inspired Engineering at Harvard University.
Nanollose Limited (ASX:NC6) Executive Chairman explains the environmentally friendly textile produced by the company for application in the fashion industry.
Nanollose Limited (ASX:NC6) (FRA:N0L) is pleased to advise that it has achieved a significant milestone in its technology commercialisation strategy, following the successful completion of its first pilot scale spin of a Nullarbor lyocell fibre.
VGI Health Technology Limited (NSX:VTL) is pleased to announce that its wholly-owned US subsidiary, Invictus Nutraceuticals, Inc. (IVN), has executed a Sales Representative Agreement with Continuum Sciences LLC of Colorado.
VGI Health Technology Limited (NSX:VTL) is pleased to announce that Dr Jordan Moon, a member of its Scientific Advisory Board, will be presenting two abstracts at the American Physiological Society's (APS) Annual Meeting Experimental Biology Conference 2022 in Philadelphia, USA.
